PHATHOM PHARMACEUTICALS, INC. (PHAT) Shareholders’ equity 2022–2025
PHATHOM PHARMACEUTICALS, INC. (PHAT) shareholders’ equity at each fiscal year-end, per SEC filings.
-$438.2MFY2025 · since FY2022: -$74.8M → -$438.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$438.2M | -72.8% |
| FY2024 | -$253.6M | -248.5% |
| FY2023 | -$72.8M | +2.7% |
| FY2022 | -$74.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice